Trademarks and Copyright© The images and information contained
in the Site are, to the fullest extent possible, copyrighted and otherwise
proprietary. It is the policy of Taro to enforce its intellectual property
rights to the fullest extent of the law, including (where applicable) seeking
criminal sanctions.
| Date | Title |
December 29, 2005
|
Taro And Alkem To Collaborate On Product Development For U.S. And Other Markets
|
November 17, 2005
|
Taro Reports Third Quarter and Nine Month 2005 Results
|
November 8, 2005
|
Taro to Report Third Quarter 2005 Results and Conduct Conference Call on November 17, 2005
|
October 26, 2005
|
Taro to Initiate Phase III Clinical Trial in the U.S. of Novel Ovide® Formulation for Control of Head Lice
|
September 23, 2005
|
Taro Receives Approval For Mupirocin Ointment USP, 2% ANDA: Generic Equivalent to Bactroban Ointment
|
September 16, 2005
|
Taro Receives FDA Approval for Alclometasone Dipropionate Cream USP, 0.05% ANDA; Tentative ANDA Approval Received for Gabapentin Capsules in 3 Strengths
|
August 10, 2005
|
Taro Receives Approval for Ciclopirox Topical Suspension USP, 0.77% ANDA; Generic Equivalent to Loprox® Topical Suspension, 0.77%
|
August 5, 2005
|
Taro Receives Approval for Halobetasol Propionate Cream, 0.05% ANDA; Generic Equivalent to Ultravate® Cream
|
August 4, 2005
|
Taro Receives Approval for Hydrocortisone Butyrate Cream USP, 0.1% ANDA; Generic Equivalent to Locoid® Cream
|
April 26, 2005
|
Taro Reports Financial Results for the Company's 1st Quarter, ended March 31, 2005
|
April 20, 2005
|
Taro to Report First Quarter 2005 Results and Conduct Conference Call on April 26, 2005
|
April 14, 2005
|
Taro Receives Approval for Ciclopirox Olamine Cream USP, 0.77%
Generic Equivalent to Loprox(R) Topical Cream
|
March 3, 2005
|
Taro to divest ElixSure® and Kerasal® OTC products to Alterna under exclusive license
|
March 2, 2005
|
Taro Receives Approval for Miconazole Nitrate Vaginal Cream, 4% ANDA
|
February 24, 2005
|
Taro Reports 4th Quarter and Full Year 2004 Results
|
January 20, 2005
|
Taro Receives Approval for Terconazole Vaginal Cream, 0.4% ANDA; Generic Equivalent to Terazol-R- 7 Vaginal Cream
|